What Sparsentan’s Approval Means for FSGS Care | Docwire News Kirk Campbell, MD, president of the National Kidney Foundation, discusses the FDA's approval of sparsentan to treat focal segmental glomerulosclerosis (FSGS).

🔗 www.docwirenews.com/post/what-sp...
What does the approval of the first drug to treat #FSGS mean for clinicians and patients? Kirk Campbell, MD, president of the National Kidney Foundation, weighs in. #nephrology #nephsky #glomerulardisease @kidney.org

Overcoming Barriers to Semaglutide Treatment for Patients With CKD | Docwire News Glucagon-like peptide-1 (GLP-1) receptor agonists like semaglutide are beneficial for chronic kidney disease (CKD), but cost and other barriers to use are a challenge.

🔗 www.docwirenews.com/post/overcom...
Semaglutide has strong renal benefits, but cost and clinical inertia pose a barrier to its use. Katherine Tuttle offered advice on how to overcome the challenges and get this valuable therapy to patients. #kidneydisease #CKD #nephrology #nephsky

Global Lessons in Scaling AI-Based Chronic Kidney Disease Screening | Docwire News Salvatore Viscomi, MD, CEO of Carna Health, discusses how the company responsibly scales AI-enabled chronic kidney disease screening around the globe.

🔗www.docwirenews.com/post/global-lessons-in-s...
Watch our interview with Dr. Salvatore Viscomi, CEO of Carna Health, on leveraging AI-enabled, population-level screening for #CKD. #nephrology #nephsky #kidneydisease #AI #artificialintelligence

Sibeprenlimab’s Approval Ushers in New Era for IgAN Treatment | Docwire News Researchers Vlado Perkovic, MBBS, PhD, and Dana Rizk, MD, are featured in a discussion of sibeprenlimab and other B-cell therapies for IgA nephropathy (IgAN).

🔗 www.docwirenews.com/post/sibepre...
Vlado Perkovic and Dana Rizk weigh in on the promise of sibeprenlimab for IgA nephropathy. #nephrology #igan #iganephropathy #nephsky

A Patient Perspective on Evolving ADPKD Care | Docwire News Anna Gaddy, MD, of the Nephrology Times editorial board discusses the patient’s perspective on autosomal dominant polycystic kidney disease (ADPKD) diagnosis and management.

🔗 www.docwirenews.com/post/a-patie...
👀 DID YOU SEE? @annagaddy.bsky.social discusses the patient’s perspective on autosomal dominant polycystic kidney disease diagnosis and management. #nephrology #adpkd #kidneydisease #nephsky

Challenges to Posttransplant Immunosuppression Adherence | Docwire News Maria Litchfield of Thermo Fisher Scientific discusses barriers that kidney transplant recipients face in maintaining immunosuppressive therapy and how clinicians can help.

🔗 www.docwirenews.com/post/challen...
🎯 DON'T MISS our interview with Maria Litchfield of Thermo Fisher about the challenges of immunosuppression adherence after kidney transplant. #nephrology #nephsky #kidneytransplant #transplantation

When One Resignation Breaks the System | Docwire News Sarah Tolson advises nephrology practices on how to build operational resilience to handle change and crises without disruption to financial stability or patient care.

🔗 www.docwirenews.com/post/when-on...
💲 ⚕️ In her latest column, Sarah Tolson advises #nephrology practices on building #resilience to withstand the unexpected without compromising financial stability or patient care continuity. #nephsky

AI at the Edges | Docwire News Artificial intelligence (AI) is making its way into clinical practice. This article presents experts' opinions on how nephrologists can best prepare.

🔗 www.docwirenews.com/post/ai-at-t...
In our April cover story, we discuss how #AI is making its way into #nephrology practice, and how clinicians can best prepare for the future. #artificialintelligence #nephsky

Proposed Loan Changes Put Nursing Education at Risk | Docwire News Natalia Barolín, RN, senior health policy advisor at Johns Hopkins School of Nursing, discusses how a proposed student loan rule change could affect nursing.

🔗 www.docwirenews.com/post/propose...
How could a proposed student loan rule with new limits for graduate nursing degrees affect the profession and patient care? Natalia Barolín, senior health policy advisor at Johns Hopkins School of Nursing, weighs in. #nursing

Evolving Methods, Changing Attitudes Usher in a New Era in CKD Research | Docwire News Hiddo Heerspink, PhD, discusses how shifts in trial design, methodology, and regulatory attitudes are helping to advance chronic kidney disease (CKD) research.

🔗 www.docwirenews.com/post/evolvin...
Prof. Hiddo Heerspink spoke with us about how changing trial designs, methodologies, and regulatory attitudes are ushering in a new era for #CKD research. #nephsky #nephrology #clinicaltrials #kidneydisease

Renal Physicians Association Annual Meeting: Q&A With the Program Chair | Docwire News Nephrology Times spoke to Katherine Kwon, program chair of the Renal Physicians Association 2026 Annual Meeting, about what the event offers nephrology professionals.

🔗 www.docwirenews.com/post/renal-p...
Attending the Renal Physicians Association Annual Meeting later this month? in this Q&A, program chair Dr. Katherine Kwon explains why it's one you don't want to miss. #nephrology #nephsky

📢 Call for Abstracts is now open for #KidneyWk

Bring research abstracts or clinical case reports to a global stage. Share discoveries, gain recognition, and be part of the work shaping the future of kidney health.

🗓️ Deadline: Wednesday, May 13, 2:00 p.m. EDT
🔗http://asn.kdny.info/eAP450YB1rU

🔗 www.docwirenews.com/journal/apri...
NO FOOLING ... Our April issue is here, featuring AI in kidney care, a Q&A with the new president of ANNA, research updates, and much more. #nephrology #nephsky

A Patient Perspective on Evolving ADPKD Care | Docwire News Anna Gaddy, MD, of the Nephrology Times editorial board discusses the patient’s perspective on autosomal dominant polycystic kidney disease (ADPKD) diagnosis and management.

🔗 www.docwirenews.com/post/a-patie...
Neph Times board member @annagaddy.bsky.social discusses the patient’s perspective on autosomal dominant polycystic kidney disease diagnosis and management. #nephrology #nephsky #ADPKD

ISN to Honor Award Winners at World Congress of Nephrology | Docwire News The International Society of Nephrology will honor award recipients at the ISN World Congress of Nephrology 2026 on March 28-31 in Yokohama, Japan.

🔗 www.docwirenews.com/post/isn-to-...
The World Congress of Nephrology starts Saturday. Learn more about the award recipients to be honored during the event. #nephrology #ISNWCN

Pragmatic Trials and Nephrology | Docwire News Nephrologist and researcher Laura Dember, MD, discusses the promise and limitations of pragmatic trials in nephrology.

🔗 www.docwirenews.com/post/pragmat...
In this Q&A, Laura Dember, MD, discusses pragmatic trials and their relevance to nephrology. #nephrology #nephsky #clinicaltrials

New Kidney Care Partners Chair Shares Vision and Key Hurdles for Progress in Kidney Care | Docwire News Kidney Care Partners chair LaVarne Burton discusses her vision and key challenges challenges faced by patients, families, and healthcare professionals dealing with kidney disease.

www.docwirenews.com/post/new-kid...
In this Q&A, incoming Kidney Care Partners chair LaVarne Burton shares her vision and key challenges for patients, families, and healthcare professionals dealing with kidney-related diagnoses. #nephrology #nephsky #kidneycare #kidneydisease

P-CABs Linked With Lower Risk for Kidney Decline Than PPIs | Docwire News A study suggests potassium-competitive acid blockers (P-CABs) may be safer for kidney function than proton pump inhibitors (PPIs) for people with chronic kidney disease (CKD).

🔗 www.docwirenews.com/post/p-cabs-... ICYMI: Potassium-competitive acid blockers (P-CABs) may be safer for kidneys than PPIs, a recent study shows. #nephrology #nephsky #renalfunction #acidblockers

Formedics - AI Use Among Physician CredSpark is a powerful, interactive content platform that helps organizations maximize the potential of their audience. What don't you know about your audience? Let's find out.

AI tools are starting to appear in daily clinical workflows. We are running a short survey to understand how physicians use AI today.

Share which tools you use and how they fit into your practice. The survey takes about 3 minutes—we would appreciate your input!

🔗 app.credspark.com/assessments/...

Setting the Agenda for Nephrology Nursing | Docwire News Nephrology Times spoke with the incoming president of the American Nephrology Nurses Association (ANNA), Michelle Gilliland, MSN, RN, CNN, about her priorities for 2026-27.

🎣 Did you catch our interview with Michelle Gilliland? She'll assume the role of ANNA president in late April. Here, she discusses key challenges faced by nephrology nurses and her priorities for the coming year. #nephrology #nephsky #nursing
🔗 www.docwirenews.com/post/setting...

Filling the Gap | Docwire News When they practice to the full extent of their education and licensure, nurse practitioners are well positioned to address the nephrology workforce shortage.

🔗 buff.ly/hdrIaTh
Nurse practitioner Molly Cahill weighs in on how NPs can bolster the nephrology workforce. #nephrology #nursing #nephsky

🏃‍♂️ 🏃 CATCH UP with the latest #nephrology content. Join our email list for the latest updates.
➡️ www.docwirenews.com/page/subscribe

Kidney News in Brief: Evolving Donor Sources and Protections, Povetacicept Edging Closer to Approval | Docwire News Nephrology news includes organ donor sources and protections, updates on povetacicept for IgA nephropathy, a renal denervation pilot, and a partnership on rare kidney diseases.

🔗 www.docwirenews.com/post/kidney-...
Recent #nephrology headlines include legislation to protect organ donors, promising povetacicept results, and more. #nephsky

Is It Time for Universal CKD Screening? | Docwire News With the burden of chronic kidney disease (CKD) on the rise, is it time to consider universal screening, or continue with a targeted strategy to prioritize high-risk populations?

🔗 www.docwirenews.com/post/is-it-t...
The cover story of our current print issue weighs the question: Should we implement universal screening for CKD? #nephrology #nephsky #ckd #kidneydisease #healthscreening

Patient Balance Collections During Deductible Season | Docwire News Sarah Tolson of Sceptre Management explains how nephrology practices can collect patient balances early in the year, the critical time when deductibles reset.

🔗 www.docwirenews.com/post/patient...
💡 Sarah Tolson of Sceptre Management Solutions offers tactics for collecting patient balances early in the year. #nephrology #nephsky #reimbursement #patientcollections

5 Nephrologists, 1 Question: Initiating Dialysis With Borderline Indications | Docwire News In this recurring section, Nephrology Times asked five nephrologists: How do you decide when to initiate dialysis for a patient with borderline indications?

We asked 5 nephrologists how they decide when to initiate dialysis for a patient with borderline indications. #nephrology #nephsky #dialysis #kidneydisease
🔗 www.docwirenews.com/post/5-nephr...

In this interview, Dr. Howard Trachtman discusses targeted therapies for FSGS, including BI 764198, a TRPC6 inhibitor that was the subject of a recent study published by The Lancet. #kidneydisease #FSGS #nephrology #nephsky buff.ly/CvQ7u8J

🎺It's here! ➡️ www.docwirenews.com/journal/marc...
Check out our latest issue online, featuring universal CKD screening, patient collection strategies, the role of neph NPs, and much more. #nephrology #nephsky

The Connection Between CKD and Cognitive Decline | Docwire News Sumair Akhtar, MD, MHCDS, of Strive Health discusses the connection between chronic kidney disease (CKD) and cognitive decline.

Dr. Sumair Akhtar offers a clinician’s perspective on why cognitive decline in CKD is multifactorial, difficult to detect, and essential to confront head-on. #kidneydisease #ckd #cognitivedecline #nephrology #nephsky www.docwirenews.com/post/the-con...

5 Nephrologists, 1 Question: Impactful Glomerulonephritis Research | Docwire News In this recurring section, Nephrology Times asked five nephrologists: What recent research has most changed your approach to managing glomerulonephritis?

❓️ ICYMI: We asked 5 nephrologists, "What recent research has most changed your approach to managing glomerulonephritis?" #nephrology #nephsky #glomerulonephritis #kidney @sophia-kidney.bsky.social @brycebarr.bsky.social
www.docwirenews.com/post/5-nephr...